Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

Mise à jour : Il y a 4 ans
Référence : NCT02653053

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This phase II trial studies the side effects and how well pazopanib hydrochloride works in treating patients with advanced thyroid cancer. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by stopping blood flow to the tumor.


Critère d'inclusion

  • Recurrent Thyroid Gland Carcinoma,Stage III Differentiated Thyroid Gland Carcinoma,Stage III Thyroid Gland Medullary Carcinoma,Stage IVA Differentiated Thyroid Gland Carcinoma,Stage IVA Thyroid Gland Medullary Carcinoma,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma,Stage IVB Differentiated Thyroid Gland Carcinoma,Stage IVB Thyroid Gland Medullary Carcinoma,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma,Stage IVC Differentiated Thyroid Gland Carcinoma,Stage IVC Thyroid Gland Medullary Carcinoma,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma,Thyroid Gland Undifferentiated (Anaplastic) Carcinoma

Liens